SAN ANTONIO, Sept. 9, 2024 /PRNewswire/ — Owl Therapeutics (“Owl”), a clinical-stage biopharmaceutical company specializing in artificial intelligence (AI) and diagnostic-powered neurotherapeutics for Traumatic Brain Injury (TBI) and related indications, will present its novel clinical…